483 Taro Pharmaceuticals U.S.A. Feb 2008

483 Taro Pharmaceuticals U.S.A. Feb 2008

Paul Mouris FDA$119.00 - Available Now

FDA investigators audited the Taro Pharmaceuticals U.S.A. - Hawthorne, NY, United States facility and issued 4 inspectional observations (via FDA 483) on 01 Feb 2008.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 01 Feb 2008
  • Location: Hawthorne, United States
  • FEI: 2435212
Add To Cart